Multiple myeloma

Multiple myeloma (MM) is a malignant tumor of plasma cell characterized by overproduction of abnormal plasma cells in the bone marrow and skeletal destruction. The clinical features are bone pain, renal impairment, immunodeficiency, anemia and presence of abnormal immunoglobulins (Ig).

Dyspnea

Difficult or labored breathing.


Total: 14

                      


(per page)
PMID (PMCID)
31266689
OTHER
Extramedullary Plasmacytoma Involving the Trachea: A Case Report and Literature Review.
Jizzini MN, Shah M, Yeung SJ.
J Emerg Med. 2019;:.
We describe a patient with a history of multiple myeloma who presented with voice hoarseness and dyspnea and was found to have airway obstruction due to an extramedullary plasmacytoma near the larynx.
31179146
OTHER
Rare Differential Diagnosis of Dyspnea: Extramedullary Plasmocytoma (EMP) of the Larynx-Case Report and Review of the Latest Literature of Laryngeal EMP and Laryngeal Involvement of Multiple Myeloma.
Steinke KV, Schneider BK, Welkoborsky HJ.
Case Rep Otolaryngol. 2019;2019:5654014.
Rare Differential Diagnosis of Dyspnea: Extramedullary Plasmocytoma (EMP) of the Larynx-Case Report and Review of the Latest Literature of Laryngeal EMP and Laryngeal Involvement of Multiple Myeloma.
26786028
FEMALE
Heart failure secondary to carfilzomib-induced heart block in multiple myeloma patients.
Tjionas H, Gupta AK.
J Oncol Pharm Pract. 2017;23(2):152-156.
In this case report, we describe a 70-year-old female with multiple myeloma presenting to the emergency department with complaint of dyspnea.
24100255
MALE Middle Aged
Development of acute pulmonary hypertension after bortezomib treatment in a patient with multiple myeloma: a case report and the review of the literature.
Akosman C, Ordu C, Eroglu E, Oyan B.
Am J Ther. 2015;22(3):e88-92.
Herein, we report a 57-year-old man with newly diagnosed multiple myeloma admitted with dyspnea, fever, and hypotension on the third day of the first dose of bortezomib therapy.
26587302
(4637487)
OTHER
Diaphragmatic Amyloidosis Causing Respiratory Failure: A Case Report and Review of Literature.
Novikov A, Holzer H, DeSimone RA, Abu-Zeinah G, Pisapia DJ, Mark TM, Pastore RD.
Case Rep Oncol Med. 2015;2015:917157.
We describe a case of a 70-year-old Caucasian man with multiple myeloma who presented with worsening dyspnea.
24822124
OTHER
Flail chest stabilization with Nuss operation in presence of multiple myeloma.
Lee SA, Hwang JJ, Chee HK, Kim YH, Lee WS.
J Thorac Dis. 2014;6(5):E43-7.
The patient presented with paradoxical movement of the thoracic wall and sternum instability due to multiple myeloma, which led to severe dyspnea, hypoxemia, hypercapnea, and bedridden state.
23303035
FEMALE Middle Aged
Secondary plasma cell leukemia.
Rotaru I, Gaman G, Dumitrescu D, Foarfa C.
Rom J Morphol Embryol. 2012;53(4):1073-6.
We report a patient who was diagnosed with multiple myeloma, 12 months earlier; he was treated with VBCMP, VCMP regime, and after 12 months he presented of high grade fever, weakness, palpitations, loss of appetite, bone pains, dyspnea.
20376900
(2852803)
MALE
Nonspecific interstitial pneumonitis after bortezomib and thalidomide treatment in a multiple myeloma patient.
Kang W, Kim JS, Cho SH, Kim SK, Chang J, Park MS.
Yonsei Med J. 2010;51(3):448-50.
Here, we describe a patient with dyspnea and diffuse pulmonary infiltrates while receiving bortezomib and thalidomide in combination with dexamethasone for treatment-naive multiple myeloma.
21294490
FEMALE Middle Aged
Plasmacytoma in the thyroid.
Kandil EH, Abdel Khalek MS, Alabbas HH, Thethi T, Crawford BE, Jaffe BM.
J La State Med Soc. 2010;162(6):338-40, 342.
PATIENT MATERIAL AND METHODS: The patient presented with compressive symptoms, including dyspnea and dysphagia and had no documented prior history of multiple myeloma.
19514509
MALE
[Case of thalidomide-induced interstitial pneumonia].
Matsushima H, Oda T, Yamamoto M, Sato A, Hasejima N, Takezawa S.
Nihon Kokyuki Gakkai Zasshi. 2009;47(5):438-42.
A 68-year-old man with multiple myeloma was admitted to our hospital complaining of slight fever and dyspnea on effort 4 months after treatment with thalidomide.
24256968
OTHER
An unusual cause of dyspnea: myelomatous involvement of cricoid cartilage. A case report.
Ozturk M, Mavili E, Gorkem SB, Cagli S, Yuce I.
Neuroradiol J. 2008;21(4):584-6.
Herein, we describe a patient with worsening dyspnea due to involvement of the cricoid cartilage with multiple myeloma.
12746663
MALE
[Pleural effusion as a first sign of Ig D lambda multiple myeloma].
Maachi M, Fellahi S, Diop ME, Francois T, Capeau J, Bastard JP.
Ann Med Interne (Paris). 2003;154(1):70-2.
We report a case of Ig D lambda multiple myeloma in a 74-year-old man that was revealed by pleural effusion and dyspnea.
12372201
MALE
[Lung toxicity due to thalidomide].
Carrion Valero F, Bertomeu Gonzalez V.
Arch Bronconeumol. 2002;38(10):492-4.
We describe the case of a 65-year-old man with multiple myeloma (IgG kappa) in stage IA who, on the thirty-seventh day of treatment with thalidomide, developed acute coughing, general malaise, dyspnea at rest and sudoresis.
2750441
MALE Middle Aged
Cytology of plasma cell myeloma in bronchial washing.
Riazmontazer N, Bedayat G.
Acta Cytol. 1989;33(4):519-22.
A 60-year-old man presenting with cough, dyspnea and chest pain was found to have plasma cell myeloma with pulmonary involvement.